Trials / Completed
CompletedNCT02694367
Expression of EPK in Recurrent Miscarriage
MAP Kinase Signaling Pathways Through ERK and p-ERK Protein in Human Placenta of Women With Recurrent Miscarriage
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 39 (actual)
- Sponsor
- Assiut University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The present study is based on hypotheses that some as yet unknown genetic factors may result in recurrent miscarriage (RM). Consequently, the main aim of this study was to gain new information about the underlying genetic causes of RM in the Egyptian population and to investigate the expression of ERK and p-ERK protein in human placenta and their corresponding tissue, to assess the significance of MAPK signal pathway in progression of recurrent miscarriage and PI3K-Akt Pathway.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Investigate the MAP kinase signaling pathways through ERK and p-ERK proteins |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-12-01
- Completion
- 2016-01-01
- First posted
- 2016-02-29
- Last updated
- 2016-02-29
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02694367. Inclusion in this directory is not an endorsement.